DRD1 and lung carcinoma: Although there were no suitable datasets collected from lung cancer trials, data from two recent clinical trials of nivolumab in advanced melanoma [49, 50] were used to compare patient response to treatment when patients were stratified by level of DRD1 mRNA expression.